Search reports.
Allergy Diagnostics Market Share, Growth, Opportunities 2031
Get free sample report Request for Customiztion Buy Now

Allergy Diagnostics Market Share, Growth, Opportunities 2031

Segments - Global Allergy Diagnostics Market by Products & Services (Instruments, Consumables, and Services), Allergens (Food, Inhaled, Drug, and Others), Test Type (In Vitro Tests and In Vivo Tests), End-users (Hospital-based Laboratories, Diagnostic Laboratories, Academic Research Institutes, and Others), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-3881 | 4.9 Rating | 84 Reviews | 220 Pages | Format : PDF Excel PPT

Report Description


The global allergy diagnostics market size was valued at USD 4.8 billion in 2021 and is expected to surpass USD 8.2 billion by 2028, expanding at a CAGR of 11.1% during the forecast period, 2021–2028. Growing environmental pollution levels across the globe and rising healthcare insurance access are driving the allergy diagnostics market.

Allergy Diagnostics Market Key Takeaways

An allergy is an immune system hypersensitivity condition. When a person's immune system reacts to molecules in the environment called allergens, an allergic reaction occurs. Dust mites secretion, pollen, and pet dander are allergens that damage the immune system. Food allergies, skin allergies, dust allergies, insect sting allergies, medication allergies, and mold allergies are all examples of allergies. Food allergies are caused by the ingestion of specific proteins found in foods, and they can produce symptoms such as rashes and stomach issues. Medication, immune system disorders, and infections can cause skin allergies, which emerge as itchy, red, swollen, bumpy, and scaly skin. Dust allergies are caused by dust mites, pollen, pet hair, mold, and cockroaches, and can enhance asthma symptoms. Insect sting allergies can cause pain, swelling, and redness at the sting site. An allergic reaction to certain components in medications causes drug allergy, which can produce symptoms such as skin rash, hives, itchy eyes, and facial swelling. Mold allergy is produced by microscopic fungus spores floating through the air, which can cause symptoms including watery eyes, runny nose, itchy lips, and sneezing.

Allergies can affect anyone at any age; however, young children are particularly vulnerable to allergic disorders. Red eyes, itching, swelling, a runny nose, and asthma attacks are all common allergy symptoms. The term ‘allergy diagnostics’ refers to the process of detecting the nature of an allergic condition and determining how to treat it. Skin prick, intradermal, blood, and patch tests are commonly employed tests used to diagnose allergies. More than one billion individuals worldwide suffer from allergic disorders. According to the Centers for Disease Control and Prevention (CDC) each year, over 50 million people in the US suffer from various types of allergies. Allergies are the 6th greatest cause of chronic illness in the US, according to the American College of Allergy, Asthma, and Immunology (ACAAI), and the yearly cost of allergies exceeds USD 18 billion.

According to a National Health Interview Survey (NHIS) study from 2014, in the US over 8% of children under the age of 18 had hay fever, and 10% had asthma. Respiratory allergies account for 5.4%, food allergies for 5.4%, and skin allergies for 11.6%.

  • Increasing prevalence of allergy across the globe is expected to boost the market in the coming years. The number of patients with allergies is rapidly increasing, and the number is expected to grow in the future. According to the World Allergy Organization (WAO), allergy incidence would rise from 15% to 40% in every country by 2030.
  • Rising environmental pollution levels is anticipated to drive the market during the forecast period.
  • High exposure to environmental pollutants in cities and prevalence of allergy disorders among urban residents is expected to fuel the market. According to the WHO, more than 80% of people living in cities are exposed to air quality levels that exceed the WHO safety guidelines; while this is a global trend, its consequences are particularly severe in low-income countries' metropolitan regions.
  • High cost of allergy diagnostics instruments is estimated to hinder the market during the forecast period.
  • The allergy diagnostics market is projected to grow rapidly in emerging economies such as India, China, and Brazil due to the increase in the prevalence of lifestyle diseases, rising awareness of health and obesity, and improving in infrastructure in these nations.

Scope of the Report

The report on the global allergy diagnostics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Allergy Diagnostics Market – Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018-2019

Forecast Period

2021-2028

Segmentation

Products & Services (Instruments, Consumables, and Services), Allergens (Food, Inhaled, Drug, and Others), Test Type (In Vitro Tests and In Vivo Tests), End-users (Hospital-based Laboratories, Diagnostic Laboratories, Academic Research Institutes, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

Thermo Fisher Scientific, Siemens Healthcare GmbH, Danaher., Omega Diagnostics Group PLC, bioMérieux India Private Limited, Romer Labs Division Holding GmbH, EUROIMMUN Medizinische Labordiagnostika AG, Jubilant Pharma Holdings Inc., NEOGEN Corporation., Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, R-Biopharm AG, AESKU.GROUP GmbH, and ACON Laboratories, Inc.

Global Allergy Diagnostics Market Segment Insights

Based on products & services, the allergy diagnostics market is divided into instruments, consumables, and services. The consumables segment is expected to account for a key share of the market during the forecast period. Growing prevalence of allergies and rising need for quick testing to diagnose allergic disorders fuel the growth of the consumables segment.

Allergy Diagnostics Market By Products & Services

In terms of allergens, the market is segregated into food allergens, inhaled allergens, drug allergens, and others. The inhaled allergens segment is projected to account for a considerable share of the market owing to the rising environmental pollution and increasing pollen coupled with other factors including mold, fungus, and dust.

On the basis of test type, the allergy diagnostics market is segmented into in vitro tests and in vivo tests. The vivo tests segment is anticipated to account for a significant share of the market during the forecast period. Increase in acceptance of various in vivo tests, such as skin prick tests, is driving the segment. In comparison to in vitro tests, these tests are dependable, safe, convenient, and cost-effective.

In terms of end-users, the allergy diagnostics market is segregated into hospital-based laboratories, diagnostic laboratories, academic research institutes, and others. The diagnostic laboratories segment is projected to account for a considerable share of the market during the forecast period. The demand for appropriate diagnosis from a professional increases awareness regarding the management of allergic disorders, and the availability of funds for the establishment of independent diagnostic laboratories are fueling the segment.

Allergy Diagnostics Market By End Users

On the basis of regions, the global allergy diagnostics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. In 2020, North America held the dominant share of the market. Increase in incidences of allergies, favorable reimbursements for allergy diagnosis, and availability of supportive activities by associations fuel the market in North America.

Segments

By Products & Services
  • Instruments
  • Consumables
  • Services
By Allergens
  • Food Allergens
  • Inhaled Allergens
  • Drug Allergens
  • Other
By Test Type
  • In Vitro Tests
  • In Vivo Tests
By End-users
  • Hospital-based Laboratories
  • Diagnostic Laboratories
  • Academic Research Institutes
  • Others
By Regions
  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East &Africa
By Key Players
  • Thermo Fisher Scientific
  • Siemens Healthcare GmbH
  • Danaher
  • Omega Diagnostics Group PLC
  • bioMérieux India Private Limited
  • Romer Labs Division Holding GmbH
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Jubilant Pharma Holdings Inc
  • NEOGEN Corporation
  • Eurofins Scientific
  • Minaris Medical America, Inc
  • Stallergenes Greer
  • R-Biopharm AG
  • AESKU.GROUP GmbH
  • ACON Laboratories, Inc.

Competitive Landscape

Key players in the global allergy diagnostics market are Thermo Fisher Scientific, Siemens Healthcare GmbH, Danaher., Omega Diagnostics Group PLC, bioMérieux India Private Limited, Romer Labs Division Holding GmbH, EUROIMMUN Medizinische Labordiagnostika AG, Jubilant Pharma Holdings Inc., NEOGEN Corporation., Eurofins Scientific, Minaris Medical America, Inc., Stallergenes Greer, R-Biopharm AG, AESKU.GROUP GmbH, and ACON Laboratories, Inc.

Allergy Diagnostics Market By Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Allergy Diagnostics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Allergy Diagnostics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Allergy Diagnostics Market - Supply Chain
  4.5. Global Allergy Diagnostics Market Forecast
     4.5.1. Allergy Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Allergy Diagnostics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Allergy Diagnostics Market Absolute $ Opportunity
5. Global Allergy Diagnostics Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Allergy Diagnostics Market Size and Volume Forecast by End Users
     5.3.1. Hospital-based Laboratories
     5.3.2. Diagnostic Laboratories
     5.3.3. Academic Research Institutes
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Allergy Diagnostics Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Allergy Diagnostics Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Allergy Diagnostics Demand Share Forecast, 2019-2026
7. North America Allergy Diagnostics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Allergy Diagnostics Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Allergy Diagnostics Market Size and Volume Forecast by End Users
     7.4.1. Hospital-based Laboratories
     7.4.2. Diagnostic Laboratories
     7.4.3. Academic Research Institutes
     7.4.4. Others
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Allergy Diagnostics Demand Share Forecast, 2019-2026
8. Latin America Allergy Diagnostics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Allergy Diagnostics Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Allergy Diagnostics Market Size and Volume Forecast by End Users
     8.4.1. Hospital-based Laboratories
     8.4.2. Diagnostic Laboratories
     8.4.3. Academic Research Institutes
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Allergy Diagnostics Demand Share Forecast, 2019-2026
9. Europe Allergy Diagnostics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Allergy Diagnostics Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Allergy Diagnostics Market Size and Volume Forecast by End Users
     9.4.1. Hospital-based Laboratories
     9.4.2. Diagnostic Laboratories
     9.4.3. Academic Research Institutes
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Allergy Diagnostics Demand Share Forecast, 2019-2026
10. Asia Pacific Allergy Diagnostics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Allergy Diagnostics Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Allergy Diagnostics Market Size and Volume Forecast by End Users
     10.4.1. Hospital-based Laboratories
     10.4.2. Diagnostic Laboratories
     10.4.3. Academic Research Institutes
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Allergy Diagnostics Demand Share Forecast, 2019-2026
11. Middle East & Africa Allergy Diagnostics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Allergy Diagnostics Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Allergy Diagnostics Market Size and Volume Forecast by End Users
     11.4.1. Hospital-based Laboratories
     11.4.2. Diagnostic Laboratories
     11.4.3. Academic Research Institutes
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Allergy Diagnostics Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Allergy Diagnostics Market: Market Share Analysis
  12.2. Allergy Diagnostics Distributors and Customers
  12.3. Allergy Diagnostics Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Thermo Fisher Scientific
     12.4.2. Siemens Healthcare GmbH
     12.4.3. Danaher
     12.4.4. Omega Diagnostics Group PLC
     12.4.5. bioMérieux India Private Limited
     12.4.6. Romer Labs Division Holding GmbH
     12.4.7. EUROIMMUN Medizinische Labordiagnostika AG
     12.4.8. Jubilant Pharma Holdings Inc
     12.4.9. NEOGEN Corporation
     12.4.10. Eurofins Scientific
     12.4.11. Minaris Medical America, Inc
     12.4.12. Stallergenes Greer
     12.4.13. R-Biopharm AG
     12.4.14. AESKU.GROUP GmbH
     12.4.15. ACON Laboratories, Inc.

Methodology

Our Clients

Deloitte
General Electric
The John Holland Group
Honda Motor Co. Ltd.
Siemens Healthcare
General Mills
Pfizer
Dassault Aviation